News
The U.S. Food and Drug Administration (FDA) has approved Cobenfy (xanomeline and trospium chloride) capsules for oral use for the treatment of schizophrenia in adults. It is the first antipsychotic drug approved to treat schizophrenia that targets cholinergic receptors as opposed to dopamine receptors, which has long been the standard of care. "Schizophrenia is a [...]
National law firm, Slater and Gordon, has launched the search for its new Charity of The Year, aimed at supporting charities that make a significant impact in their communities and to the lives of their patrons. The Charity of the Year Award will support a new charity each year, and Slater and Gordon will make [...]
Scientists have pinpointed the melatonin receptor MT1 as a crucial regulator of REM (Rapid Eye Movement) sleep, marking a significant breakthrough in the understanding of sleep mechanism that holds new promise for treating sleep disorders and associated neuropsychiatric conditions. REM sleep is crucial for dreaming, memory consolidation, and emotional regulation. In the brain, the melatonin [...]
A new three-year research programme, bringing together charities, universities and global pharmaceutical giants, is aiming to understand Parkinson's in unprecedented detail. The Landmark project brings together Parkinson’s UK, Imperial College London, GSK, Novartis, Roche and UCB for the first time, and is backed by £4m from the Gatsby charitable foundation. Parkinson’s is the fastest growing [...]
Brain injury and homelessness was the focus of a recent UK conference attended by neuro-rehab professionals. Held at Sheffield Hallam University, more than 120 delegates attended to hear from those with lived experience of brain injury and homelessness as well from those working to improve the lives of people living with an acquired or traumatic [...]
You have until September 30 to get your nominations in for the second annual NR Times awards - that's just one week today. The awards celebrate the best in neuro and spinal injury rehab, with winners announced as a virtual ceremony on November 29. The entries will be judged by each category sponsor, with the [...]
A study based on clinical trial data found higher risks of stroke, heart attack, and hospital admission for heart failure in older cancer survivors. In the analysis published in CANCER, a peer-reviewed journal of the American Cancer Society, chemotherapy was also linked to elevated rates of these conditions. Although advances in treatment have led to decreased [...]
A novel drug molecule could potentially lead to new treatments to prevent Parkinson’s disease in younger patients, according to new research. While Parkinson’s symptoms — slowed movements, tremors and balance problems — often appear in people in their 60s, five to 10 per cent of people are diagnosed before they turn 40. A new study [...]
A pioneering study has identified critical biomarkers that can predict disability worsening in MS. The breakthrough research has the potential to transform treatment strategies for millions of MS patients worldwide, paving the way for more personalised and effective treatment plans. The multicentre observational study, presented yesterday at the world's largest MS research congress, ECTRIMS 2024, [...]
You have just two weeks left to get your nominations in for the second annual NR Times Awards. The event, delivered in partnership with headline sponsor Elysium Healthcare, will recognise the very best of brain and spinal injury rehab across the UK and beyond. Nominations close on September 30, after which the NR Times team [...]
